The high tissue retention associated with albumin nanoparticles may be useful for therapeutic regimes such as lung cancer treatment with inhaled nanomedicines [26], which would benefit patients by providing high, sustained drug concentrations in the lung tissue and low systemic drug exposure. The gene discussed is ALB; the disease is lung carcinoma.